Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Introduction to Language of Pathophysiology ll01:17

Introduction to Language of Pathophysiology ll

69
This lesson explores key terms that describe how diseases progress, their outcomes, and their distribution in populations.Diagnostic tests identify diseases and monitor treatment. These include blood and urine tests, biopsies, imaging (X-ray, MRI), and detection of infectious agents.Remission is a reduction or disappearance of symptoms.Exacerbation refers to the worsening of symptoms, such as increased wheezing during an asthma attack.A precipitating factor triggers an acute episode, while a...
69
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

31
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
31

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Abnormal B-Cell Exosome Proapoptotic and Antiapoptotic Cargo in Multiple Sclerosis: Potential Implication in Progressive Disease Biology.

Neurology(R) neuroimmunology & neuroinflammation·2026
Same author

Workforce Investments in Telehealth Suicide Prevention in Emergency Departments: Implementation Costs of a Centralized Behavioral Health Consultation Service.

The journal of behavioral health services & research·2026
Same author

Bruton's tyrosine kinase inhibitors: a new class of multiple sclerosis therapeutics.

The Lancet. Neurology·2026
Same author

Progression to Wheelchair in Secondary Progressive Multiple Sclerosis and Impact of Siponimod: Post Hoc Analyses From the EXPAND Study.

European journal of neurology·2026
Same author

Development and Validation of a Large Language Model Case Identification Strategy for Eosinophilic Esophagitis.

Gastro hep advances·2026
Same author

Efficacy and safety of a bodyweight-adjusted higher dose of ocrelizumab in relapsing (MUSETTE) and primary progressive (GAVOTTE) multiple sclerosis: two multicentre, randomised, double-blind, parallel-group phase 3b trials.

Lancet (London, England)·2026
Same journal

Trust, Reproducibility, and Progress: The Roles of Independent Blind Prediction and Assessment and Benchmarking in Computational Biology.

Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing·2026
Same journal

The Evolving Cyberinfrastructure at the National Institutes of Health to Support Data and AI in Biomedical Research.

Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing·2026
Same journal

Applications of AI & ML in Biomanufacturing of Cell and Gene Therapies.

Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing·2026
Same journal

AI for Health: Leveraging Artificial Intelligence to Revolutionize Healthcare.

Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing·2026
Same journal

Workshop Introduction: Advances of AI Methods in Single Cell Spatial Omics.

Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing·2026
Same journal

DRIVE-KG: Enhancing variant-phenotype association discovery in understudied complex diseases using heterogeneous knowledge graphs.

Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing·2026
See all related articles

Related Experiment Video

Updated: May 5, 2026

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.8K

Leveraging Large Language Models to Derive Multiple Sclerosis Progression Assessments from Clinical Notes: A

Sy Hwang1, Sunil Thomas2, Heather Williams2

  • 1Institute for Biomedical Informatics, Perelman School of Medicine University of Pennsylvania, Philadelphia, PA, USA, sy.hwang@pennmedicine.upenn.edu.

Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing
|February 27, 2026
PubMed
Summary
This summary is machine-generated.

This study explored using large language models (LLMs) to analyze clinical notes for multiple sclerosis (MS) progression. The goal was to develop a feasible classifier for EDSS and FS scores from patient records.

More Related Videos

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

11.2K
Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
03:14

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness

Published on: December 6, 2024

1.3K

Related Experiment Videos

Last Updated: May 5, 2026

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.8K
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

11.2K
Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
03:14

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness

Published on: December 6, 2024

1.3K

Area of Science:

  • Neurology
  • Artificial Intelligence
  • Clinical Informatics

Background:

  • Accurate assessment of multiple sclerosis (MS) progression is crucial for patient care and research.
  • Key progression indicators are often embedded within unstructured clinical notes.
  • Current methods for extracting this data can be labor-intensive.

Purpose of the Study:

  • To evaluate the feasibility of developing and validating a large language model (LLM)-based classifier.
  • To ascertain multiple sclerosis (MS) progression using clinical notes.
  • To extract Expanded Disability Status Scale (EDSS) and Functional Systems (FS) scores automatically.

Main Methods:

  • Development of a large language model (LLM) classifier.
  • Utilizing clinical notes as the data source.
  • Validation of the LLM's performance in classifying MS progression indicators.

Main Results:

  • The study assessed the feasibility of the LLM-based approach.
  • Preliminary findings indicate potential for automated MS progression ascertainment.
  • Further validation is required to confirm accuracy and reliability.

Conclusions:

  • Developing an LLM-based classifier is a feasible approach for MS progression ascertainment from clinical notes.
  • This method holds promise for improving efficiency in clinical care and research.
  • Future work should focus on robust validation and integration into clinical workflows.